ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02274766

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:42.899302+00:00

Published At

2018-01-10T00:00:00+00:00

Record Updated At

2018-01-10

Results Posted At

2018-01-10

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Dyskinesia", "Levodopa-Induced Dyskinesia (LID)", "Parkinson\u0027s Disease (PD)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-01-10"

protocolSection.identificationModule.nctId

"NCT02274766"

protocolSection.identificationModule.officialTitle

"ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson\u0027s Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-01-10"

Study condition terms

• Dyskinesia (protocolSection.conditionsModule.conditions)
• Levodopa-Induced Dyskinesia (LID) (protocolSection.conditionsModule.conditions)
• Parkinson's Disease (PD) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.